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Selective vulnerability of subpopulations of neurons is a striking
feature of neurodegeneration. Mitochondrially transmitted dis-
eases are no exception. In this study CNS tissues from a patient
with myoclonus epilepsy and ragged red fibers (MERRF) syn-
drome, which results from an A to G transition of nucleotide (nt)
8344 in the mitochondrial tRNALys gene, were examined for the
proportion of mutant mtDNA. Either individual neuronal somas
or the adjacent neuropil and glia were microdissected from
cryostat tissue sections of histologically severely affected brain
regions, including dentate nuclei, Purkinje cells, and inferior
olivary nuclei, and from a presumably less affected neuronal
subpopulation, the anterior horn cells of the spinal cord. Mutant
and normal mtDNA were quantified after PCR amplification with
a mismatched primer and restriction enzyme digestion. Neu-
rons and the surrounding neuropil and glia from all CNS regions
that were analyzed exhibited high proportions of mutant
mtDNA, ranging from 97.6 6 0.7% in Purkinje cells to 80.6 6
2.8% in the anterior horn cells. Within each neuronal group that
was analyzed, neuronal soma values were similar to those in the
surrounding neuropil and glia or in the regional tissue homog-
enate. Surprisingly, as compared with controls, neuronal loss
ranged from 7% of the Purkinje cells to 46% of the neurons of
the dentate nucleus in MERRF cerebellum. Thus, factors other
than the high proportion of mutant mtDNA, in particular nuclear-
controlled neuronal differences among various regions of the
CNS, seem to contribute to the mitochondrial dysfunction and
ultimate cell death.
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Selective vulnerability of neuronal or glial subpopulations is a
feature of many neurological diseases. The myoclonus epilepsy
and ragged red fibers (MERRF) syndrome is characterized by
myoclonic epilepsy, cerebellar ataxia, and progressive muscular
weakness. In this maternally inherited disease (Wallace et al.,
1988) the symptoms of myoclonic epilepsy, ataxia, and muscular
weakness may reflect severe pathological changes in neurons of
the dentato-rubral and the spinocerebellar pathways and of the
inferior olivary nuclei and in skeletal muscle. The myopathic
changes include the generation of ragged red fibers indicative of
proliferation and subsarcolemmal accumulation of mitochondria.
The MERRF syndrome is most commonly the result of a single
base pair substitution at position 8344 in the mitochondrial
tRNALys gene (Shoffner et al., 1990, 1991; Yoneda et al., 1990;
Chomyn et al., 1991; Hammans et al., 1993; Silvestri et al., 1993).
The relationship between mtDNA genotype and phenotype of
selective neuronal vulnerability has not been defined. It is not
known whether the affected neurons contain more mutant
mtDNA, either in their somas or in their processes within the
surrounding neuropil, than neurons in the relatively spared re-
gions, or, alternatively, whether differences in nuclear gene activ-
ity play a crucial role in determining the degree of damage to
various neuronal populations. In particular, important variables
differentially affecting cell survival may include demand for oxi-
dative phosphorylation of different cell types and the terminally
differentiated state of the neuron.
Previous quantifications of the mutant mtDNA proportion in
the CNS have been made in tissue homogenates of anatomical
regions (Tanno et al., 1993; Sanger and Jain, 1996). However,
these samples contained not only neurons but the surrounding
glia, including oligodendrocytes, astrocytes, and microglia as well
as blood vessels. Furthermore, these analyses could not distin-
guish neuronal somas from dendrites, axons, and synaptic termi-
nals that form the surrounding neuropil.
In the present study we have compared neuronal loss with the
percentage of mutant mtDNA in the more severely and the less
severely affected neuronal groups. Individual neuronal somas
were microdissected from CNS tissue sections. Mutant and nor-
mal mtDNA were quantified after PCR amplification with a
mismatched primer and restriction enzyme digestion (Zeviani et
al., 1991; Yoneda et al., 1991). Four neuronal subpopulations
were compared: Purkinje cells and neurons of the dentate nuclei
of the cerebellum and neurons of the inferior olivary nuclei of the
medulla, all heavily vulnerable, and motor neurons of the spinal
cord anterior horns, a presumably less-affected neuronal sub-
population. Three types of samples from each neuronal group
Received Feb. 27, 1997; revised July 15, 1997; accepted July 30, 1997.
These studies were supported by Grants from the National Institute of Aging
(P50-AG05142) and the National Institute of Mental Health (5R37-MH39145) to
C.A.M. and from the National Institute of General Medical Sciences (GM-11726) to
G.A. We are grateful to Ms. Jeanette Espinosa and Carol Church for their excellent
secretarial assistance, to Dr. Roger Duncan of the School of Pharmacy, University
of Southern California, for assistance with quantitative densitometry, and to Drs.
Karen Jain and Terence Sanger for helpful discussions.
Correspondence should be addressed to Dr. Carol A. Miller, Department of
Pathology, University of Southern California School of Medicine, 2011 Zonal
Avenue, Los Angeles, CA 90033.
Copyright © 1997 Society for Neuroscience 0270-6474/97/177746-08$05.00/0
The Journal of Neuroscience, October 15, 1997, 17(20):7746–7753
were analyzed: neuronal somas only, neuropil and glia only, and
homogenates of regions, including entire neuronal groups (neu-
ronal somas plus neuropil and glia).
MATERIALS AND METHODS
CNS tissue. CNS tissues were obtained 20 hr postmortem from a 14-year-
old Hispanic female with clinical and neuropathologically confirmed
MERRF syndrome (Sanger and Jain, 1996). Paraffin-embedded CNS
tissue sections (7 mm) were stained with hematoxylin and eosin. Control
tissues for histology were obtained postmortem from an age-matched
patient who died from non-neurological causes.
Neuronal loss was compared in MERRF and control tissues in four
sections from each paraffin block. Neurons were counted at 2503 mag-
nification in five fields of either dentate nuclei or inferior olivary nuclei,
or in the entire bilateral anterior horn region of the lower cervical and
upper thoracic spinal cord, or Purkinje cells in five foliar loops. Counts
were confirmed in all sites by two independent observers. The mean
values were calculated for each.
For PCR analysis, blocks of tissue (1 cm 3) were dissected at autopsy,
immediately snap-frozen in liquid nitrogen-chilled isopentane, and
stored at 290°C. Four neuronal subpopulations were selectively ana-
lyzed: the Purkinje neurons and dentate nuclei neurons of the cerebel-
lum, the inferior olivary nuclei neurons of the medulla, and motor
neurons from the anterior horns of the spinal cord. Two types of samples
were examined from each neuronal group: pooled neuronal somas and
neuropil with glia. The dissected Purkinje cell somas also were analyzed
individually. Maternal and patient’s leukocytes were each prepared for
PCR, using the same procedure as for the CNS tissues. Snap-frozen
postmortem CNS tissues from one neurologically normal patient (age 40)
were used for PCR analysis.
Neuronal dissection. Cryostat tissue sections (35 mm) were stained with
1% toluidine blue in 1% Na-borate in water for 30 sec and then rinsed in
water until the excess stain was removed. Stained slides were viewed with
an inverted microscope. Individual neurons were dissected out and
suctioned into a glass micropipette guided by a Narashige micromanip-
ulator (Narashige Scientific Instrument Lab, Tokyo, Japan). The pipette
system consisted of a siliconized, 1-mm-diameter thin glass micropipette
(World Precision Instruments, Sarasota, FL). Fine tips for dissection
were prepared, using a model P-77 Brown-Flaming micropipette puller
(Sutter Instrument, San Francisco, CA) at a heater temperature setting
of 30 for 7 sec. The tip was gently, manually broken to yield an opening
of ;50 mm diameter. The blunt end was inserted into Tygon SILASTIC
tubing [0.02 inches inner diameter (i.d.)], which was connected to amber
latex rubber tubing (1/8 inch i.d.). A disposable syringe (30 ml) tip was
inserted into the latex tubing, and gentle suction was provided to the
system. Before isolation of the neuronal somas, the field was moistened
with one or two drops of TE buffer (10 mM Tris-HCl, pH 7.6, and 1 mM
EDTA). Neuropil plus glia samples included the residual tissue imme-
diately surrounding the site of the neuronal soma after its dissection.
After isolation of the neuronal somas or neuropil, the samples were
transferred into separate microfuge tubes and centrifuged at 12,800 3 g
for 2 min. The supernatant fluid was removed and replaced with DNA
extraction solution (50 mM Tris-HC1, pH 8.5, 1 mM EDTA, and 0.5%
Tween 20, containing 200 mg/ml proteinase K). The samples were
incubated at 55°C for 2 hr and then immediately heated at 95°C for 10
min to inactivate the proteinase K.
PCR amplification of mtDNA. For PCR analysis, 20 –30 neuronal
soma isolates from either a specific nucleus or neuronal subpopulation
were pooled in 50 ml of digestion buffer. Thus, ;2.5 soma equivalents
were included in each reaction sample of 10 ml. Neuropil samples were
obtained from sections after the removal of somas. For tissue samples,
material from ;100 mm 2 areas that included neuronal somas, neuropil,
and glia was isolated from a tissue section. For “single-cell” analyses
two Purkinje cell soma sections (approximately one soma equivalent)
were isolated in 25 ml of digestion buffer.
The PCR conditions were based on the method of Zeviani et al.
(1991). For the PCR reaction the following pair of primers was used,
corresponding to mtDNA positions (59-39) 8278–8297 and (39-59) 8385–
8345 (according to the Cambridge sequence, Anderson et al., 1981). The
backward primer introduced mismatches at positions 8352 (C-C) and
8353 (T-C) that create, in combination with the A3G transition at
position 8344, a restriction site for the enzyme BglI in the amplified
fragments from the mutant, but not the wild-type, mtDNA.
The extracted DNA was combined with 20 pmol of primer 1 and 40
pmol of primer 2, 1.5 mM MgCl2 , and 0.4 ml (2 U) of Taq polymerase
(Perkin-Elmer, Norwalk, CT). The mixture was brought to a final
volume of 50 ml by the addition of distilled H20, and then it was submitted
to an initial 30 cycle PCR amplification. The template DNA was added to
the reaction mixture after it was heated to 90°C, before the thermal
cycling was started. The PCR protocol involved an initial incubation at
95°C for 5 min before cycling. The cycling procedure then followed, with
a 30 sec incubation at 94°C for denaturation, a 30 sec annealing step at
55°C, and a 30 sec elongation at 72°C. The addition of 1.5 U of Taq
polymerase was followed by 10 more PCR cycles. For some experiments
the PCR product was purified after the initial 30 cycles by the Gene-
Clean Kit II (BIO-101, Vista, CA). The DNA purification step, however,
reduced significantly the final amount of the product. In such cases we
then performed an additional 30 cycles as described above, after mixing
300 ng of purified DNA and 25 ml of a PCR reaction mixture and adding
distilled H20 to a final volume of 50 ml.
The PCR product plus 300 ng of pBluescript II SK (pBS II) DNA,
added to each tube as an internal marker to assess completeness of
digestion, were digested with 25 U of BglI (Fisher, Pittsburgh, PA) from
2 hr to overnight at 37°C. Samples of the digestion products were
electrophoresed on a 1% agarose gel for detection of the pBS II and on
a nondenaturing 12% polyacrylamide gel (29:1 acrylamide/bis-
acrylamide) to detect the mutant mtDNA. The molecular weight marker
for the agarose gels was a 1 kb DNA ladder (Life Technologies, Gaith-
ersburg, MD) and HinfI-digested fX174 (Promega, Madison, WI) for
the polyacrylamide gel. The ethidium bromide-stained gels were photo-
graphed with Polaroid instant film (positive–negative), type 55.
To quantify the percentages of mutant and wild-type genomes, we
used a BioImage laser densitometer. The data were corrected for the
presence of heteroduplexes resistant to BglI digestion, formed in the last
PCR cycle, by using a standard curve (Yoneda et al., 1994).
RESULTS
Typical histological features of MERRF syndrome, character-
ized by neuronal cytoplasmic eosinophilia, striking shrinkage of
many of the remaining neurons, and astrocytic gliosis, were seen
in all sites that were examined (Fig. 1). The most severe changes
were in the dentate nucleus, and the Purkinje cells were the least
involved. Neuronal counts (Fig. 2) indicated a 46% reduction in
the number per unit area of dentate nucleus neurons as compared
with an age-matched control. Furthermore, there was a 29% loss
of inferior olivary nucleus neurons and a comparable reduction
(28%) of spinal motor neurons of the lower cervical and upper
thoracic segments. By contrast, there was a striking preservation
of Purkinje cells, with no significant loss.
For PCR analysis Purkinje cells, neurons of the dentate and
inferior olivary nuclei, and a motor neurons from the cervical or
thoracic spinal cord were microdissected individually. As shown
in Figure 3, for Purkinje cells and neurons of the inferior olivary
nucleus, individual somas were isolated intact with nearly total
exclusion of the surrounding neuropil. The isolated Purkinje cells
either were analyzed in pairs or were pooled in samples of 20–30
somas.
The results of BglI digestion of the PCR fragments amplified
from the DNA of the four different regions of the CNS are shown
in Figure 4. For each site the samples included pooled, isolated
neuronal somas and homogenates of nondissected tissue sections
(Fig. 4A–C). A sample of neuropil minus the neuronal somas is
shown in Figure 4B, and DNA from the equivalent of an indi-
vidual Purkinje cell is shown in Figure 4C.
The presence of mutant mtDNA with the A3G substitution at
bp 8344 was observed in all MERRF tissue samples. Using
ethidium bromide stain, we detected a pattern of three bands by
polyacrylamide gel electrophoresis. Two bands corresponded to
the expected 35 and 73 bp products of cleavage of the PCR
fragments at the BglI site created from the mutant template. The
third band corresponded to the 108 bp uncut PCR product
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Figure 1. Tissue sections stained with hematoxylin and eosin of cerebellum (A, B), dentate nucleus (C, D), inferior olivary nucleus (E, F ), and anterior
horns of the thoracic spinal cord (G, H ). A, C, E, and G show tissues from the neurologically normal individual; B, D, F, and H show tissues from the
MERRF syndrome patient. In the diseased tissues neurons exhibit shrunken somas when compared with the normal control samples. In the control
cerebellum there is an artifactual separation of the Purkinje cells from the underlying internal granule layer. Scale bar, 40 mm.
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derived from wild-type DNA (Fig. 4A, lane 1). Depending on the
tissue site and sample, the three bands were present in variable
amounts (Fig. 4A–C). The exclusive presence of pBluescript
DNA cleavage products of 1694 and 1267 bp in the agarose gel
indicates the virtually complete extent of BglI digestion (Fig. 4D).
An additional band of ;60 bp was seen occasionally, especially
in samples with small quantities of DNA, such as those derived
from individual Purkinje cells (Fig. 4D, lane 2) and in a control
sample lacking template DNA but containing the primers (Fig.
4C, lane 3). The 39 ends of the two primers used for PCR were
complementary in four of the five terminal bases. If the primers
annealed to each other and were extended by the polymerase, a
56 bp product would have been expected. Therefore, the >60 bp
band most likely resulted from primer dimerization rather than
from degradation.
Quantification of the results revealed that the mean percentage
of mutant mtDNA was high in all four anatomical areas, but it was
the highest in the Purkinje neurons (96.7% 6 0.7% in the indi-
vidual cells and 90.5 6 0.5% in the pooled cells; Fig. 5). The
motor neurons of the anterior horn of the spinal cord had a
statistically significant or nearly significant lower proportion of
mutant mtDNA (84.3 6 4.2%; p , 0.06, when compared with the
pooled Purkinje cells; p , 0.01, when compared with the individ-
ual Purkinje cells). The neurons of the dentate nuclei of the
cerebellum and those of the inferior olivary nuclei of the medulla
contained intermediate proportions of mutant mtDNA (89.0 6
1.5% and 86.2 6 3.8%, respectively).
There were comparable values of the percentage of mutant
mtDNA in tissue samples within each CNS region. Thus, samples
of cerebellar cortical homogenates showed a mutant DNA pro-
portion similar to that of the Purkinje cell component. Omitting
the toluidine blue tissue stain caused no quantitative or qualita-
tive changes in the PCR amplification or BglI cleavage of the PCR
product (Fig. 5, lane 2). Internal granule cells exhibited slightly
lower proportions of mutant DNA than Purkinje cells (88.8 6
1.3%; Fig. 5). In the other CNS regions the mutant mtDNA
proportion determined for the tissue homogenate or the neuropil
was only slightly lower than that found in the isolated neurons.
DNA from individually microdissected Purkinje cells subjected
in pairs to PCR amplification of the mtDNA component revealed
remarkably similar proportions of mutant DNA from pair to pair,
with mean values of 96.7% 6 0.7% (Fig. 5, lane 3). Such a small
error suggests that the variability is minimal from cell to cell.
Shrunken somas contained the same amount of the mutant form
as histologically normal neighboring neurons (data not shown).
There is no obvious explanation for the ;5% difference between
individual and pooled Purkinje cell somas. Overall, results
pointed to a relatively homogeneous distribution of mutant
mtDNA in a given region regardless of cell class or whether
samples were restricted to neuronal somas or neuropil only.
DISCUSSION
In the present study regional and single neuronal PCR analyses
have revealed high percentages of mutant mtDNA in all of the
CNS neuronal populations tested. There were, however, differ-
ences in the proportion of mutant mtDNA among the neuronal
populations analyzed, with the Purkinje cells exhibiting the high-
est proportion (90–97%), the motor neurons of the spinal cord
anterior horns exhibiting a statistically significant lower propor-
tion (84%), and the neurons of dentate nuclei and of the inferior
olivary nuclei exhibiting intermediate percentages (89 and 86%,
respectively). Tanno et al. (1993), using quantitative PCR analysis
of whole tissue samples of specific brain regions, also found only
small differences in the proportion of mutant mtDNA among
different brain regions. Our results, obtained at a higher level of
resolution, agree with their findings.
In the present work the separation of neuronal somas from the
surrounding tissue also has allowed the analysis of the distribu-
tion of the mutant mtDNA among neuronal somas and neuropil.
Thus, the slight differences observed in mutant mtDNA propor-
tion between neuronal somas and the surrounding neuropil would
tend to exclude a segregation of the mutant mtDNA exclusively or
predominantly in neurons or in glia.
The microdissection of neuronal somas from specific regions of
the brain from the MERRF patient also has permitted a compar-
ison of the histopathology with the percentage of mutant mtDNA
in these regions. Thus, the high proportion of mutant mtDNA did
not correlate directly with the histopathology, including neuronal
loss. This discrepancy was especially striking for Purkinje neu-
rons. “Individual” somas of residual Purkinje cells consistently
showed the highest percentage of mutant mtDNA among the
brain regions analyzed (97%), yet there was remarkably little loss
of these neurons (7%). There was no significant individual vari-
ability among these neurons in their proportion of mutant DNA.
Only slightly lower proportions of mutant mtDNA were found in
the neurons of the dentate nucleus, as compared with Purkinje
cells. However, in striking contrast to the latter cells, .45% of
neurons were lost in this nucleus. This loss may be relevant to the
clinical manifestation of myoclonic epilepsy.
There are several possible explanations for the discrepancy
between the proportion of mutant mtDNA and the neuronal loss
discussed above. As evidenced by the selective vulnerability to
hypoxia (Brierly et al., 1973), requirements for oxidative phos-
phorylation differ among neuronal subpopulations. In fact, differ-
ential use of the glycolytic pathway may exist among such popu-
lations. Other mechanisms, such as excitotoxicity, may be
triggered by mitochondrial dysfunction in glutamatergic neurons
Figure 2. Bar graph representing the percentage of remaining neurons in
different CNS regions. The number of neurons per microscopic field (at
2503 magnification) was determined as described in Materials and Meth-
ods. The bars represent the ratios of the mean number in the MERRF
sections to the mean number in the control sections. Error bars represent
the SEM.
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(Schinder et al., 1996). It is also possible that a different vulner-
ability to apoptosis of neurons harboring mtDNA mutations from
various CNS regions (Asoh et al., 1996) plays a role in the
phenomenon observed here. In this connection it is worth noting
that a nonuniform susceptibility to cell death also may account for
the differences in proportion of mutant mtDNA found among the
various neuronal subpopulations. Thus, it is possible that the
neurons of the olivary nuclei and the motor neurons of the spinal
Figure 3. Microdissection procedure. The tissue sections of cerebellum are stained with 1% toluidine blue. A, The neuron to be removed (arrow) is
targeted by the tip of a glass micropipette. B, The neuron is drawn into the glass micropipette. C, The same section is shown after suction of the neuronal
soma. Scale bar, 70 mm. D, Neurons (arrows) in the inferior olivary nucleus. E, The same section after the neurons have been removed by syringe suction.
Scale bar, 50 mm.
Figure 4. Results of BglI digestions of the PCR fragments amplified from the DNA of three different regions of the CNS. The top band is the 108 bp
wild-type mtDNA fragment. The two lower bands are the 35 and 73 bp fragments derived from mutant mtDNA. A, Regional tissue compared with pooled
neuronal isolates. Unmarked lane, Size marker, fX174 digested with HinfI. Lane 1, Uncut; lane 2, inferior olivary nucleus, tissue; lane 3, inferior olivary
nucleus, neuronal somas; lane 4, dentate nucleus, tissue; lane 5, dentate nucleus, neuronal somas; lane 6, spinal cord, tissue; lane 7, spinal cord, motor neuron
somas; lane 8, MERRF patient’s blood; lane 9, mother’s blood. B, Regional tissue compared with neuropil. Unmarked lane, Size marker, as in A. Lane 1,
Dentate nucleus, tissue; lane 2, dentate nucleus, neuropil. C, Regional tissue compared with a single neuron. Lane 1, Cerebellar tissue; lane 2, single Purkinje
cell equivalent; lane 3, primers only, no DNA (arrow indicates primer dimer). D, pBluescript II SK as DNA internal marker of digestion with BglI. Unmarked
lane, Size marker, 1 kb DNA ladder. Lane 1, Complete digestion; lane 2, uncut. The bottom band is supercoiled DNA; the top band is relaxed circular DNA.
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cord would degenerate and die when a certain level of mutant
mtDNA (85%) is reached. Therefore, the maximum proportion
of mutant mtDNA would be lower in these neuronal populations
than in other neurons, such as Purkinje cells, which could survive
with a higher level of mutant mtDNA.
Recent studies by Enriquez et al. (1995) demonstrate that, in
cells carrying the MERRF mutation in nearly homoplasmic form,
the mutant mitochondrial tRNA Lys is present at moderately but
significantly decreased levels. This tRNA is functional, although
it exhibits a reduced capacity to be charged by the specific syn-
thetase. However, the reduced level of charged tRNA Lys per cell,
i.e., .50–60% of the normal level, is not sufficient to support
normal respiratory chain function. An addition of a minimum of
10% wild-type mtDNA is required for full respiratory compe-
tence (Yoneda et al., 1994; Attardi et al., 1995). These observa-
tions were made on transmitochondrial cell lines carrying the
MERRF mutation, which were constructed by transfer of the
patient’s mitochondria into human mtDNA-less cells (Chomyn et
al., 1991). A threshold effect also was reported by Larsson et al.
(1992), who observed that .92% of mutant mtDNA was required
for causing respiratory chain dysfunction in muscle. Boulet et al.
(1992) obtained comparable findings in myoblast cultures derived
from muscle biopsies of MERRF patients. Therefore, comple-
mentation of the mutation in individual heteroplasmic mitochon-
dria and/or the residual functional capacity of the mutant
mtDNA may support sufficient oxidative phosphorylation for
maintaining cell viability in certain cell types.
The cellular model of the MERRF syndrome mentioned above
has been used recently to study the rules that govern complemen-
tation of the mutation (Yoneda et al., 1994; Attardi et al., 1995).
It is reasonable to think that the distribution of mutant mtDNA
among mitochondria and the threshold of wild-type mtDNA
required for complementation vary among different cell types in
the CNS. Thus, the most plausible interpretation of the results
obtained in the present work is that the nuclear gene activity plays
an important role in the phenotypic manifestation of the
MERRF mutation (Lertrit et al., 1992), as has been shown for
other disease-causing mtDNA mutations (Harding et al., 1995;
Guan et al., 1996). This possibility is supported by the fact that
the nt8344 mutation can be associated with other phenotypes
(Silvestri et al., 1993).
The sensitivity of PCR amplification extended to the single-cell
level and the reliability of the dissection under direct visualization
described in the present work provide a powerful method for
analyzing, at the cellular level, the distribution of an mtDNA
mutation, which is applicable to other mtDNA-linked diseases
affecting the CNS. In contrast to in situ PCR, quantification of
mutant mtDNA is possible in single neurons. Resolution of dissec-
tion at the light microscopic level followed by PCR is, in fact, higher
than that achievable by applying PCR directly to sections (O’Leary
et al., 1996). Application of single-cell dissection and analysis of
mRNA expression have been made in cultures (Lambolez et al.,
1992; Mackler et al., 1992). Recently, this method has been ex-
tended to formalin-fixed paraffin-embedded tissues obtained from
CNS of patients with tuberous sclerosis, a disease that affects
nuclear gene expression of tuberin (Crino et al., 1996).
Single muscle fiber PCR analysis has been applied previously to
tissue sections from patients carrying either the mitochondrial
encephalomyopathy, lactic acidosis, and stroke-like episodes
(MELAS) nt3243 mutation (Moraes et al., 1992; Petruzzella et
al., 1994) or an mtDNA deletion (Sciacco et al., 1994). Either
microcapillaries or a fine metal probe was used for cell retrieval.
Figure 5. Bar graph representing the
percentage of mutant mtDNA in differ-
ent CNS regions. Each bar represents
the mean of two to six determinations by
PCR and gel analysis of the proportion
of mutant DNA in the specified tissue or
neuronal isolate. The gel analysis was
done on at least two pools of each type
of sample (some pools were sampled
more than once for PCR and gel analy-
sis), with the exception of blood. Seven
determinations were made on one sam-
ple of the patient’s blood. neuron, Neu-
ronal soma; Purkinje cells, Purkinje cell
soma; neuropil, the material immedi-
ately surrounding the neuronal soma
collected after the soma was removed;
tissue, material including somas, neuro-
pil, and glia from a tissue section. The
bar labeled individual Purkinje cells rep-
resents the mean of six pairs of Purkinje
soma halves. The proportion of mutant
DNA in each pair is 97.3, 97.6, 96.5,
95.8, 97.0, and 95.6%. The error bars
represent 2 SEM.
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Analysis of serial sections of muscle from a MELAS patient
histochemically stained for cytochrome c oxidase activity shows a
direct correlation between the localized accumulation of the
nt3243 MELAS mutation and the impairment of cytochrome c
oxidase function of the single muscle fiber (Petruzzella et al.,
1994). There is significant heterogeneity in the proportion of
mutant mtDNA from fiber to fiber and along the length of the
fiber. In apparent contrast to these results are those obtained by
Shoubridge (1993), who applied the same method to the analysis
of skeletal muscle from a MERRF patient carrying the 8344
mutation in the tRNALys genes. In this study the mtDNA was
predominantly mutant in all the fibers, but the cytochrome c
oxidase activity varied from fiber to fiber, giving a fully positive
or a deficient or virtually absent staining reaction. There seemed
to be no correlation between genotype and phenotype. Similarly,
Sparaco et al. (1995) found a mosaic pattern of staining of
neurons, including Purkinje cells, from a MERRF patient who
exhibited a moderate proportion of mutant DNA in brain (55% in
brain total DNA and 59% in brain mitochondrial DNA; Lombes
et al., 1992) when they used antisera directed against cytochrome
c oxidase subunit II. The data that we have obtained in the
present work on the Purkinje cell pairs would suggest that, among
those cells, the level of mutant mtDNA varied very little from cell
to cell. Thus, the mosaic phenotype observed by Sparaco et al.
(1995) may have arisen from a failure of the residual wild-type
DNA to complement the mutant DNA in some cells because of an
unfavorable segregation of the two genotypes within the cells. In
fact, previous evidence clearly indicates that, in addition to the
proportion of mutant and wild-type mtDNAs in a cell, the way in
which the two types of mtDNA are distributed among the or-
ganelles has an important role in determining the phenotypic
manifestation of the mutation (Shoubridge, 1993; Yoneda et al.,
1994; Attardi et al., 1995).
Further analysis by the method described here of CNS tissues
from this and other patients carrying the MERRF or other
mtDNA mutations, in conjunction with a determination of respi-
ratory chain activity at the single-cell level, is needed to define
the relationship of mitochondrial genotype to phenotype in mu-
tant neurons. Sensitivity at the level of the single soma isolate is
within reach with the present method and would allow for the
identification of any heterogeneity of mtDNA distribution as well
as an examination of the possible mechanisms leading to loss of
cell function and death. These probably include a variety of
nuclear gene-controlled factors that contribute to the partitioning
of mutant mtDNA within the mitochondria in a cell, to neuro-
protection, or to selective vulnerability of neurons to oxidative
stress or apoptosis.
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